Cite
HARVARD Citation
Mkannez, G. et al. (2018). DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease. Cardiovascular research. 114 (11), pp. 1525-1535. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mkannez, G. et al. (2018). DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease. Cardiovascular research. 114 (11), pp. 1525-1535. [Online].